296 related articles for article (PubMed ID: 31160781)
21. Structural basis for substrate specificity of heteromeric transporters of neutral amino acids.
Rodriguez CF; Escudero-Bravo P; Díaz L; Bartoccioni P; García-Martín C; Gilabert JG; Boskovic J; Guallar V; Errasti-Murugarren E; Llorca O; Palacín M
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34848541
[TBL] [Abstract][Full Text] [Related]
22. CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.
Estrach S; Lee SA; Boulter E; Pisano S; Errante A; Tissot FS; Cailleteau L; Pons C; Ginsberg MH; Féral CC
Cancer Res; 2014 Dec; 74(23):6878-89. PubMed ID: 25267066
[TBL] [Abstract][Full Text] [Related]
23. Cooperation of Antiporter LAT2/CD98hc with Uniporter TAT1 for Renal Reabsorption of Neutral Amino Acids.
Vilches C; Boiadjieva-Knöpfel E; Bodoy S; Camargo S; López de Heredia M; Prat E; Ormazabal A; Artuch R; Zorzano A; Verrey F; Nunes V; Palacín M
J Am Soc Nephrol; 2018 Jun; 29(6):1624-1635. PubMed ID: 29610403
[No Abstract] [Full Text] [Related]
24. Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability.
de la Ballina LR; Cano-Crespo S; González-Muñoz E; Bial S; Estrach S; Cailleteau L; Tissot F; Daniel H; Zorzano A; Ginsberg MH; Palacín M; Féral CC
J Biol Chem; 2016 Apr; 291(18):9700-11. PubMed ID: 26945935
[TBL] [Abstract][Full Text] [Related]
25. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
[TBL] [Abstract][Full Text] [Related]
26. The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation.
Wu D; Yan R; Song S; Swansiger AK; Li Y; Prell JS; Zhou Q; Robinson CV
Nat Commun; 2024 May; 15(1):3711. PubMed ID: 38697966
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target.
Hayashi N; Yamasaki A; Ueda S; Okazaki S; Ohno Y; Tanaka T; Endo Y; Tomioka Y; Masuko K; Masuko T; Sugiura R
Oncotarget; 2021 Jun; 12(13):1256-1270. PubMed ID: 34194623
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural immunohistochemical study of L-type amino acid transporter 1-4F2 heavy chain in tumor microvasculatures of N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) induced rat bladder carcinoma.
Kume E; Mutou T; Kansaku N; Takahashi H; Wempe MF; Ikegami M; Kanai Y; Endou H; Wakui S
Microscopy (Oxf); 2017 Jun; 66(3):198-203. PubMed ID: 28339760
[TBL] [Abstract][Full Text] [Related]
29. CD98hc in host-pathogen interactions: roles of the multifunctional host protein during infections.
Vection S; O'Callaghan D; Keriel A
FEMS Microbiol Rev; 2022 Sep; 46(5):. PubMed ID: 35595511
[TBL] [Abstract][Full Text] [Related]
30. The role of CD98 in astrocytic neoplasms.
Nawashiro H; Otani N; Shinomiya N; Fukui S; Nomura N; Yano A; Shima K; Matsuo H; Kanai Y
Hum Cell; 2002 Mar; 15(1):25-31. PubMed ID: 12126061
[TBL] [Abstract][Full Text] [Related]
31. Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hc.
Ohgaki R; Ohmori T; Hara S; Nakagomi S; Kanai-Azuma M; Kaneda-Nakashima K; Okuda S; Nagamori S; Kanai Y
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28320871
[TBL] [Abstract][Full Text] [Related]
32. Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.
Okubo S; Zhen HN; Kawai N; Nishiyama Y; Haba R; Tamiya T
J Neurooncol; 2010 Sep; 99(2):217-25. PubMed ID: 20091333
[TBL] [Abstract][Full Text] [Related]
33. Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc.
Rosell A; Meury M; Álvarez-Marimon E; Costa M; Pérez-Cano L; Zorzano A; Fernández-Recio J; Palacín M; Fotiadis D
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):2966-71. PubMed ID: 24516142
[TBL] [Abstract][Full Text] [Related]
34. Sub-Nanometer Cryo-EM Density Map of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
Jeckelmann JM; Fotiadis D
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993041
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
[TBL] [Abstract][Full Text] [Related]
36. Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation.
Napolitano L; Galluccio M; Scalise M; Parravicini C; Palazzolo L; Eberini I; Indiveri C
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):727-736. PubMed ID: 28088504
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
Nguyen NNT; Lim YS; Nguyen LP; Tran SC; Luong TTD; Nguyen TTT; Pham HT; Mai HN; Choi JW; Han SS; Hwang SB
Sci Rep; 2018 Oct; 8(1):15486. PubMed ID: 30341327
[TBL] [Abstract][Full Text] [Related]
38. The role of CD98 heavy chain in cancer development.
Park E; Kim H; Yoon S; Jang B
Histol Histopathol; 2024 Apr; ():18749. PubMed ID: 38695393
[TBL] [Abstract][Full Text] [Related]
39. The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma.
Heider M; Eichner R; Stroh J; Morath V; Kuisl A; Zecha J; Lawatscheck J; Baek K; Garz AK; Rudelius M; Deuschle FC; Keller U; Lemeer S; Verbeek M; Götze KS; Skerra A; Weber WA; Buchner J; Schulman BA; Kuster B; Fernández-Sáiz V; Bassermann F
Mol Cell; 2021 Mar; 81(6):1170-1186.e10. PubMed ID: 33571422
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.
Ueda S; Hayashi H; Miyamoto T; Abe S; Hirai K; Matsukura K; Yagi H; Hara Y; Yoshida K; Okazaki S; Tamura M; Abe Y; Agatsuma T; Niwa SI; Masuko K; Masuko T
Cancer Sci; 2019 Feb; 110(2):674-685. PubMed ID: 30548114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
